Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Medicinova Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −5 vs. Q1 2025
- Shares held
- 5.17M
- −31.6K (−0.6%) vs. Q1 2025
- Total value
- $6.77M
- −$821.1K (−10.8%) vs. Q1 2025
- New holders
- 0
- 4 more added
- Sold out
- 5
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 76 | $100 | 0.00% | −8,600−99.1% | Reduced |
| Northwestern Mutual Wealth Management Co | 305 | $400 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 412 | $540 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,462 | $4.54K | 0.00% | +234+7.2% | Added |
| Hantz Financial Services, Inc. | 4,300 | $6.00K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 34,750 | $45.5K | 0.00% | −388−1.1% | Reduced |
| SBI Securities Co., Ltd. | 43,479 | $57.0K | 0.00% | −12,600−22.5% | Reduced |
| Dimensional Fund Advisors LP | 66,215 | $86.7K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 71,506 | $93.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 76,031 | $99.6K | 0.00% | −25,000−24.7% | Reduced |
| Bank of America Corp | 94,452 | $123.7K | 0.00% | −35,528−27.3% | Reduced |
| Bank of New York Mellon Corp | 96,174 | $126.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 108,000 | $141.5K | 0.00% | +33,900+45.7% | Added |
| Northern Trust Corp | 139,738 | $183.1K | 0.00% | −1,013−0.7% | Reduced |
| State Street Corp | 174,598 | $228.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 178,700 | $234.1K | 0.00% | −3,000−1.7% | Reduced |
| UBS Group AG | 222,200 | $291.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 250,343 | $327.9K | 0.00% | +228+0.1% | Added |
| Geode Capital Management, LLC | 525,892 | $689.1K | 0.00% | −1,107−0.2% | Reduced |
| Citigroup Inc | 591,957 | $775.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 686,577 | $899.4K | 0.00% | +63,003+10.1% | Added |
| BlackRock, Inc. | 695,715 | $911.4K | 0.00% | −4,626−0.7% | Reduced |
| Essex Woodlands Management, Inc. | 1,105,941 | $1.45M | 0.52% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −26,710−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −10,264−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |